Transcriptome profiling of brain edemas caused by influenza infection and lipopolysaccharide treatment. Issue 5 (8th November 2013)

• Record Type: Journal Article
• Authors: Kyan, Yukihiro; Ueda, Yumi; Yoshida, Mitsutaka; Sasahara, Kenji; Shinya, Kyoko
• Is Part Of: Journal of medical virology. Volume 86:Issue 5(2014:May)
• Page Start: 905
• Page End: 911
• Publication Date: 2013-11-08
• Subjects: Virology -- Periodicals; 616
• DOI: 10.1002/jmv.23801
• Languages: English
• ISSNs: 0146-6615

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="jmv23801-sec-0001" sec-type="section"> <p>Influenza A virus‐associated encephalopathy triggered by influenza virus infection often occurs in children aged five and younger in Japan. However, the mechanisms behind Influenza A virus‐associated encephalopathy are not yet well understood. This study developed an Influenza A virus‐associated encephalopathy‐like model using mice infected with Influenza A virus and given lipopolysaccharide treatment. The results showed that the mice used in the model suffered from brain edemas nearly three times more severe, as well as having higher cytokine levels in sera compared to those of the control groups. Using gene expression profiling, cytokine‐related genes were found not to be up‐regulated in the brain in situ, while protein coding genes, which are known to be involved in blood–brain barrier disruption, were up‐regulated. Categorizing the functional groups using gene ontology revealed the terms "ion channels, " "calcium oscillation, " and "membrane transporter activities." The blood–brain barrier disruption found in this Influenza A virus‐associated encephalopathy model can therefore be assumed to be due to a cellular electrolyte imbalance of the neuronal tissue, in addition to a cytokine storm. <bold><italic>J. Med. Virol. 86:905–911, 2014</italic>.</bold> © 2013 Wiley Periodicals, Inc.</p> </sec> </abstract>